LOX and prostate neoplasm: Conversely, LOX mRNA expression has been found to be lower in metastatic prostate tumours than in primary prostate tumours30, and low levels of LOX expression have also been reported in high-grade tumours31, 32, suggesting loss of LOX expression during prostate tumour progression.